Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Presentation Recap: 2014 Health Care Investors Conference

Publications

November 19, 2014

Bass, Berry & Sims PLC and Deloitte co-hosted the fourth annual Health Care Investors Conference designed to connect investors with leaders in the health care industry. We discussed trends in health care investing and heard from management teams and their private equity investors about generating and fostering opportunities to create health care solutions. The conference was intended for managing directors and principals at private equity firms and executive management teams of national health care companies.

Supporting organizations included: the Entrepreneur Center, the Healthcare Private Equity Association, the Nashville Health Care Council and the Nashville Capital Network.

The full presentation deck is provided in the pdf below, and materials referenced during the program are available via the following links:

  • Deloitte M&A Trends report 2014 - Over the past 18 months, merger and acquisition (M&A) activity has accelerated in the U.S. That trend is poised to continue, if not increase, according to the first annual Deloitte M&A Trends report. Of the 2,500 corporate and private equity respondents, 84 percent of corporate executives anticipate a sustained, if not accelerated, pace of M&A activity in the next 24 months. The vast majority of private equity executives (89 percent) are expecting average to high deal activity going forward.
  • The Great Consolidation: The potential for rapid consolidation of health systems - Deloitte models estimate that after consolidation in the next decade, only 50 percent of current health systems will likely remain. Executives should consider defining how their hospitals will survive: Should they acquire? Differentiate? Seek other relationship types? Staying the course is no longer an option.

Click below to download the full presentation.

Download Document - 2014 HCIC Presentation

In Case You Missed It:

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.